【Abstract】 Objective To investigate the clinical efficacy analysis of renal retention and long term surgical treatment of ureteral transitional cell carcinoma, and provide reference for clinical research. Methods The clinical data of 35 patients underwent surgical treatment of renal retention were retrospectively analyzed. Results The age of 35 ureteral transitional cell carcinoma patients was more than 65 years and 15 cases more than 65 years. The clinical analysis demonstrated that histological grade G1 had 8 例, G2 had 15 cases, G2G3 had 6 例, G3 had 6 cases, Ta had 2 cases, T1 had 9 cases, T2 had 17 cases and T3 had 7cases. Comparison of 35 patients, there was a significant difference (P＜005) in age, tumor grade and clinical stage group. 35 patients after 6 months to 2 years of followup were carried out. 16 patients after cystoscopy found bladder cancer. The bladder cancer underwent transurethral surgery. 14 patients survived. The other two patients died of cardiovascular disease. 4 cases of patients were with ipsilateral renal pelvis cancer, renal pelvis cancer. 5 patients were with clinically confirmed ureteral stricture after regular replacement DJ tubes. 10 patients with ureteral cancer local recurrence after radical prostatectomy ureter and 8 patients survived, 2 patients died of local recurrence. 2 Years after June 31 cases of survival, the survival rate was 8857%. After 5year followup survey showed that 22 cases survived, including G1 8 例, G2 14 例, Ta2 example, T18 cases, T212 cases were lowgrade, lowstage patients. 13 deaths, mostly in patients with highgrade and high stage. Conclusion ureteral transitional cell carcinoma is clinically rare tumors of patients with kidneysparing surgery, lowgrade, lowstage patients with a good prognosis. However, the risk of having a recurrence of kidneysparing surgery, the need for close observation, take the appropriate treatment, prolong survival time.